Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study
- 381 Downloads
Correction to: Annals of Hematology
The original version of this article contained a mistake. The name of Tanja Nicole Hartman should have been Tanja Nicole Hartmann.
The original article has been corrected.
© Springer-Verlag GmbH Germany, part of Springer Nature 2018